期刊文献+

心脏型脂肪酸结合蛋白、肌钙蛋白、脑钠肽联合检测对急性肺栓塞危险分层的评估价值 被引量:6

The valuation of the combined detection of heart type fatty acid binding protein(H-FABP),BNP and troponin to the evaluation of the risk stratification in patients of acute pulmonary embolism
下载PDF
导出
摘要 目的 探讨联合检测心脏型脂肪酸结合蛋白(H-FABP)、肌钙蛋白(TnI)、脑钠肽(BNP)对急性肺栓塞危险分层的评估价值.方法 选择2013年1月至2014年1月上海市奉贤区中心医院ICU及心内科确诊的急性肺栓塞患者32例,其中男性15例,女性17例.对所有患者进行危险分层,联合检测H-FABP、TnI和BNP,行血气分析、心电图、心脏彩超等检查.根据不同危险分层选择不同的治疗方法,观察不同危险分层患者的H-FABP、TnI和BNP水平,以及患者的治疗情况,分析H-FABP、TnI和BNP对急性肺栓塞危险分层的评估价值.结果 随着急性肺栓塞危险分层的增加,H-FABP、TnI和BNP水平不断升高,高危组的数值分别为(8.4±3.1)ng/ml、(0.981±0.357)ng/ml和(2458.00±1231.28)pg/ml,阳性率为100%,患者的临床过程愈加复杂,预后变差.结论 联合检测H-FABP、TnI和BNP,可用于急性肺栓塞危险分层,指导临床决策. Objective To discuss the value of the combined detection of H-FABP, BNP and troponin to the evaluation of the risk stratification in patients of acute pulmonary embolism. Methods 32 cases of patients with acute pulmonary embolism were performed on risk stratification. All the patients were observed through combined detection of heart type fatty acid binding protein(H-FABP), cardiac troponin I(TnI ), BNP, blood gas analysis, electrocardiogram, and echocardiogram examination. Different treatment methods were selected according to the different risk stratification. The levels of H-FABP, TnI and BNP were evaluated in patients with different risk stratification and the conditions of treatment. The value of H-FABP, TnI and BNP in the evaluation of risk stratification in patients with acute pulmonary embolism was analyzed. Results With the increase of the risk stratification of acute pulmonary embolism, H-FABP, TnI and BNP levels rising, the value was (8.4±3.1)ng/ml, (0.981± 0.357)ng/ml, (2458.00±1231.28)pg/ml respectively, and the positive rate was 100%, and yet the patient's clinical process was more complex, and a worse prognosis. Conclusion H-FABP and TnI and BNP joint detection, can be used in the risk stratification of acute pulmonary embolism, and may guide the clinical decision making.
出处 《中国心血管病研究》 CAS 2014年第10期887-891,共5页 Chinese Journal of Cardiovascular Research
关键词 急性肺栓塞 心脏型脂肪酸结合蛋白 肌钙蛋白 脑钠肽 Acute pulmonary embolism Heart type fatty acid binding protein Cardiac troponin Brain natriurctie peptide
  • 相关文献

参考文献13

  • 1Pollack CV,Schreiber D,Goldheber SZ,et al.Clinical characteristics,mannagement and out-comes of patients diagnosed with acute pulmonary embolism in the emergency Department:initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry).J Am Coll Cardiol,2011,57:700-706. 被引量:1
  • 2Yang Y,Liang L,Zhai Z,et al.Pulmonary embolism incidence and fatality trends in Chinese hospitals from 1997 to 2008:a multicenter registration study.PLoS One,2011,6:e26861. 被引量:1
  • 3骆黎,吴晓贞,邓春发.肌钙蛋白联合血气分析对肺栓塞诊断及危险分层的探讨[J].临床急诊杂志,2011,12(1):19-21. 被引量:6
  • 4Logeart D,Lecuyer L,Thabut G,et al.Biomarker-based strategy for screening right ventfieular dysfunction in patients with non-massive pulmonary embolism.Intensive Care Med,2007,33:286-292. 被引量:1
  • 5中华医师协会心血管内科医师分会.急性肺血栓栓塞症诊断治疗中国专家共识.中华内科杂志,2010,49:74-80. 被引量:1
  • 6Kearon C,Kahn SR,Agnelli G,et al.Antithrom-botic therapy for venous thromboembolic disease:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).Chest,2008,133:S454-545. 被引量:1
  • 7王海鱼,王海澜,郭盛,方胜先,夏斌赞.心肌型脂肪酸结合蛋白(H—FABP)在诊断早期AMI中的临床应用[J].中国心血管病研究,2009,7(5):321-323. 被引量:4
  • 8杨喜山,代琳琳,董平栓,何海超,张东江,席欢.心型脂肪酸结合蛋白对急性心肌梗死的早期诊断价值[J].中国心血管病研究,2012,10(1):43-46. 被引量:10
  • 9Viswanathan K,Kilcullen N,Morrell C,et al.Heart type fatty acid-binding protein predicts long-term mortality and reinfarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.J Am Coll Cardiol,2010,55:2590-2598. 被引量:1
  • 10Logeart D,Lecuyer L,Thabut G,et al.Biomarker-based strategy for screening right ventficular dysfunction in patients with non-massive pulmonary embolism.Intensive Care Med,2007,33:286-292. 被引量:1

二级参考文献19

  • 1刘艳梅,翟振国,王辰.肺血栓栓塞症的病理生理学研究进展[J].国外医学(呼吸系统分册),2004,24(5):273-275. 被引量:14
  • 2王玉其,甘立军,李清贤.急性心肌梗死急诊介入治疗的临床评价[J].中国心血管病研究,2006,4(4):290-291. 被引量:7
  • 3SILVERSTEIN M D,HEIT J A,MOHR D N,et al. Trends in the incidence of deep vein thrombosis and pulmonary embolishm: a 25 year population-based study[J].Arch Intern Med,1998,158:585 593. 被引量:1
  • 4HEITJ A,COHEN A T,ANDERSON F A. VTE Im pact Assessment Group. Estimated annual number of incident and recurrent, non-fatal and fatal venous t hromboembolism (VTE) events in the U. S [J]. Blood,2005,106:267 267. 被引量:1
  • 5KONSTANTINIDES S, GEIBEL A, OLSCHEWSKI M,et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism[J]. Circulation,2002,106 : 1263 -1268. 被引量:1
  • 6BECATTIN C, VEDOVATI M C, AGNELIJI G. Prognostic value of troponins in acute pulmonary em bolism : a meta analysis[J].Circulation, 2007,116 : 427 -433. 被引量:1
  • 7HAMM C W,GIANNITSIS E,KATUS H A. Cardiac troponin elevations in patients without acute coronary syndrome[J]. Circulation, 2002,106 : 2871 - 2872. 被引量:1
  • 8KUCHER N,GOLDHABER S Z. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism[J]. Circulation, 2003,108 : 2191 - 2194. 被引量:1
  • 9Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med,2009,360:2705-2718. 被引量:1
  • 10Apple FS, Jaffe AS. Cardiac function. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. St Louis, MO:Elsevier Satmders, 2006:1619-1670. 被引量:1

共引文献17

同被引文献58

  • 1王文玲,文小平,黄韵红.希罗达/奥沙利铂联合榄香烯治疗老年进展期胃癌的临床研究[J].中国肿瘤临床,2006,33(18):1069-1070. 被引量:13
  • 2秦叔逵,龚新雷.晚期胃癌化疗的现状和新进展[J].临床肿瘤学杂志,2006,11(9):641-652. 被引量:268
  • 3库建伟,潘瑞华.奥沙利铂联合希罗达治疗晚期胃癌临床观察[J].山东医药,2007,47(1):55-55. 被引量:11
  • 4Pol lack CV, Scbreiber D, Goldheber SZ, et al. Clinical characteristics, man nagem- ent and out-comes of patients diagnosed with acute pulmonary embolism in the emergency department :initial report of EMPEROR (Multicenter Emergency Medi- cine Pulmonary Embolism in the Real World Registry)[J]. J Am Coil Card iol, 2011,57(6):700-706. 被引量:1
  • 5Yang Y, Liang, zhai Z, et al. Pulmonary embolism incidence and fatality trends in Chinese hospitals from 1997 to 2008 : am- ulticenter registration study[J].P LoS One, 2011,6(11):e26861. 被引量:1
  • 6Logeart D, Lecuyer L, Thabut G, et al. Biomarker -basedstrategy for screening right ventficular dysfunction in patients withnon-massive pulmonary embolism[J]. Intensive Care Med,2007,33(2):286-292. 被引量:1
  • 7Becattini C, Vedovati MC, Agnelli G. Prognostic value oftropunins in acute pul- monary embolism : a meta-analysis[J]. Circulation,2007,116(4):427. 被引量:1
  • 8Kearon C, Kahn SR, Agnelli G, et al. An- tithrom-botic therapy for venous thrombo- embolie disease: American College of ChestPhysicians Evidence-Based Clinical Practice Guidelines (8thEdition) [J]. C hest,2008,133(4):$454-545. 被引量:1
  • 9Bova C, Pesavento R, Marchiorl A, et al. Risk stratificationand outcomes in hem- odynamically stable patients with acute pulmonaryem bolism: a prospective, mul- ticentre, cohort study with three months of follow up[J]. J T hromb Haemost,2009,7 (6):938-944. 被引量:1
  • 10Lucena J,Rico A,Vázquez R,et al.Pulmonary embolism and sudden-unexpected death:prospective study on 2477 forensic autopsies performed at the Institute of Legal Medicine in Seville[J].J Forensic Med,2009,16(4):196-201. 被引量:1

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部